• Profile
Close

National trends, outcomes, and costs of radiation therapy in the management of low- and high-intermediate risk endometrial cancer

Gynecologic Oncology Mar 18, 2019

Suidan RS, et al. - Researchers analyzed 10,842 patients to evaluate the treatment models, consequences, and costs for females with low-(LIR) and high-intermediate risk endometrial cancer (HIR) already treated with and without adjuvant radiotherapy. They observed a significant increase in survival (60% vs 47%) among those who had radiotherapy in the HIR group, but not in those in the LIR group. They also reported an increase in costs with a higher morbidity risk with radiotherapy. They found an association of radiotherapy with an improved risk of gastrointestinal (7 vs 4%), genitourinary (2 vs 1%), and hematologic (16 vs 12%) complications.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay